Therapeutic potential of anti-ErbB3 chimeric antigen receptor natural killer cells against breast cancer.
Lee J, Song J, Yoo W, Choi H, Jung D, Choi E, Jo SG, Gong EY, Jeoung YH, Park YS, Son WC, Lee H, Lee H, Kim JJ, Kim T, Lee S, Park JJ, Kim TD, Kim SH.
Lee J, et al. Among authors: park jj.
Cancer Immunol Immunother. 2025 Jan 3;74(2):73. doi: 10.1007/s00262-024-03923-y.
Cancer Immunol Immunother. 2025.
PMID: 39751931